1. Home
  2. SVRA vs MITK Comparison

SVRA vs MITK Comparison

Compare SVRA & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • MITK
  • Stock Information
  • Founded
  • SVRA N/A
  • MITK 1983
  • Country
  • SVRA United States
  • MITK United States
  • Employees
  • SVRA N/A
  • MITK N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • MITK Computer peripheral equipment
  • Sector
  • SVRA Health Care
  • MITK Technology
  • Exchange
  • SVRA Nasdaq
  • MITK Nasdaq
  • Market Cap
  • SVRA 540.6M
  • MITK 463.1M
  • IPO Year
  • SVRA N/A
  • MITK N/A
  • Fundamental
  • Price
  • SVRA $2.80
  • MITK $10.01
  • Analyst Decision
  • SVRA Buy
  • MITK Strong Buy
  • Analyst Count
  • SVRA 7
  • MITK 4
  • Target Price
  • SVRA $9.86
  • MITK $12.63
  • AVG Volume (30 Days)
  • SVRA 966.0K
  • MITK 623.2K
  • Earning Date
  • SVRA 03-06-2025
  • MITK 12-16-2024
  • Dividend Yield
  • SVRA N/A
  • MITK N/A
  • EPS Growth
  • SVRA N/A
  • MITK N/A
  • EPS
  • SVRA N/A
  • MITK 0.07
  • Revenue
  • SVRA N/A
  • MITK $172,083,000.00
  • Revenue This Year
  • SVRA N/A
  • MITK $4.41
  • Revenue Next Year
  • SVRA N/A
  • MITK $11.12
  • P/E Ratio
  • SVRA N/A
  • MITK $143.00
  • Revenue Growth
  • SVRA N/A
  • MITK N/A
  • 52 Week Low
  • SVRA $2.60
  • MITK $7.35
  • 52 Week High
  • SVRA $5.70
  • MITK $16.24
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 39.71
  • MITK 43.63
  • Support Level
  • SVRA $2.60
  • MITK $9.96
  • Resistance Level
  • SVRA $3.14
  • MITK $10.42
  • Average True Range (ATR)
  • SVRA 0.17
  • MITK 0.33
  • MACD
  • SVRA -0.01
  • MITK -0.16
  • Stochastic Oscillator
  • SVRA 32.79
  • MITK 5.53

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: